| r1 (N=89) |
r2 (N=89) |
P-value | |
|---|---|---|---|
| Age | |||
| Mean (SD) | 51.8 (10.2) | 51.8 (10.2) | 1 |
| Median [Min, Max] | 54.0 [27.0, 74.0] | 54.0 [27.0, 74.0] | |
| Treatment | |||
| CCRT | 66 (74.2%) | 66 (74.2%) | 1 |
| Surgery | 23 (25.8%) | 23 (25.8%) | |
| Stage | |||
| II | 32 (36.0%) | 32 (36.0%) | 1 |
| III | 50 (56.2%) | 50 (56.2%) | |
| IV | 7 (7.9%) | 7 (7.9%) | |
| Metastasis_status | |||
| No | 39 (43.8%) | 39 (43.8%) | 1 |
| Yes | 50 (56.2%) | 50 (56.2%) | |
| Histology | |||
| Adenocarcinoma | 1 (1.1%) | 1 (1.1%) | 1 |
| Carcinoma.in.situ | 1 (1.1%) | 1 (1.1%) | |
| Poorly.differentiated.carcinoma | 2 (2.2%) | 2 (2.2%) | |
| Squamous cell carcinoma | 85 (95.5%) | 85 (95.5%) | |
| DFS_status | |||
| 0 | 70 (78.7%) | 70 (78.7%) | 1 |
| 1 | 19 (21.3%) | 19 (21.3%) | |
| OS_status | |||
| 0 | 87 (97.8%) | 87 (97.8%) | 1 |
| 1 | 2 (2.2%) | 2 (2.2%) | |
| DFS_months | |||
| Mean (SD) | 17.8 (12.7) | 17.8 (12.7) | 1 |
| Median [Min, Max] | 13.5 [0.433, 43.4] | 13.5 [0.433, 43.4] | |
| OS_months | |||
| Mean (SD) | 20.7 (13.1) | 20.7 (13.1) | 1 |
| Median [Min, Max] | 19.3 [0.433, 43.4] | 19.3 [0.433, 43.4] |